Novavax


Read More
Less
A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syr

Novavax COVID-19 vaccine more than 90% effective in US trial

Novavax's protein-based COVID-19 vaccine candidate was more than 93% effective against the predominant variants of COVID-19 that have been of concern among scientists and public health officials.

By REUTERS
14/06/2021
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy